Endoscope Reprocessing Market Report 2026

The endoscope reprocessing market size has grown rapidly in recent years. It will grow from $3.02 billion in 2025 to $3.4 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to hospital-acquired infection concerns, growth in endoscopic procedures, regulatory sterilization standards, reusable device adoption, hospital safety initiatives.

The endoscope reprocessing market size is expected to see rapid growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to automation in reprocessing, sustainability-driven reuse practices, infection control investments, regulatory enforcement, hospital infrastructure upgrades. Major trends in the forecast period include rising focus on infection prevention, increased use of reusable endoscopes, strict compliance with sterilization protocols, growth in automated reprocessing systems, expansion of hospital hygiene standards.

The increasing incidence of cancer is expected to support the growth of the endoscope reprocessing market in the coming years. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells to other parts of the body. The rising occurrence of cancer is largely attributed to greater exposure to environmental carcinogens, which can damage cellular DNA over time and increase the likelihood of malignant transformation. Endoscope reprocessing plays a critical role in ensuring that medical endoscopes are properly cleaned, disinfected, and safe for repeated use, thereby minimizing infection risks and supporting accurate early detection and ongoing monitoring of cancer through endoscopic procedures. For example, in May 2024, the National Institutes of Health, a US-based government agency, reported that as of January 2022, around 18.1 million individuals in the United States were living as cancer survivors, with projections suggesting this figure could increase to 22.5 million by 2032. Consequently, the growing cancer burden is driving demand for endoscope reprocessing solutions.

Key players in the endoscope reprocessing market are emphasizing the development of disinfectors with advanced cleaning and disinfection capabilities to strengthen their competitive positioning. These advanced disinfectors are essential for ensuring safe and effective endoscope reprocessing by providing thorough sterilization and reducing the risk of healthcare-associated infections. For instance, in June 2023, Olympus Corporation, a Japan-based manufacturer specializing in optics and reprography products, introduced a new endoscope washer disinfector known as the ETD (Endoscope Washer Disinfector). Available in two versions - ETD Basic and ETD Premium - this system is designed to meet the needs of high-volume endoscopy units and can reprocess up to three endoscopes simultaneously. The ETD washer disinfector serves as a vital tool in maintaining endoscope hygiene and reprocessing standards, thereby supporting patient safety and infection prevention.

In November 2023, HOYA Corporation, a Japan-based medical equipment company, acquired Wassenburg Medical, Inc. for an undisclosed amount. This acquisition was intended to accelerate innovation in endoscope reprocessing technologies by integrating Wassenburg Medical’s engineering expertise with HOYA’s flexible endoscopy division. Wassenburg Medical, Inc. is a Netherlands-based company that provides high-quality endoscope reprocessing products and solutions.

Major companies operating in the endoscope reprocessing market are Custom Ultrasonics Inc., Advanced Sterilization Products Inc., Olympus Corporation, Wassenburg Medical BV, Steris Corporation, Getinge AB, ARC Healthcare Solutions, BES Healthcare Ltd., Borer Chemie AG, Metrex Research LLC, Matachana Group SA, HOYA Corporation, Laboratories Anios, CONMED Corporation, Endo-Technik W. Griesat GmbH, Steelco S.p.A, Ecolab Inc., Belimed AG, Cantel Medical Corp., Richard Wolf GmbH, MEDALKAN, Micro-Scientific LLC, Tuttnauer USA Co. Ltd., Shinva Medical Instrument Co. Ltd., Medical Devices Group Srl, SciCan Inc.

North America was the largest region in the endoscope reprocessing market in 2025. The regions covered in the endoscope reprocessing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endoscope reprocessing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the endoscope reprocessing market by increasing costs of imported disinfectants, sterilants, and automated reprocessing equipment. Hospitals and ambulatory surgical centers in developed regions are most affected due to dependence on imported systems. These tariffs increase operational costs by raising expenses for infection control and equipment maintenance, impacting compliance efficiency. However, they support local manufacturing of reprocessing solutions, strengthening regional supply of sterilization technologies.

The endoscope reprocessing market research report is one of a series of new reports that provides endoscope reprocessing market statistics, including endoscope reprocessing industry global market size, regional shares, competitors with a endoscope reprocessing market share, detailed endoscope reprocessing market segments, market trends and opportunities, and any further data you may need to thrive in the endoscope reprocessing industry. This endoscope reprocessing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Endoscope reprocessing is a vital element of infection prevention strategies, as endoscopes are increasingly used across a wide range of surgical and diagnostic procedures. Through a validated process known as reprocessing, endoscopes and their accessories are cleaned, disinfected, or sterilized. The reuse life refers to an operator’s determination of the number of days a reusable high-level disinfectant or sterilant remains effective.

The key products involved in endoscope reprocessing include high-level disinfectants and test strips, detergents and wipes, automated endoscope reprocessors, endoscope drying, storage, and transport systems, endoscope tracking solutions, and others. A test strip is a device used to measure the concentration of a chemical or other properties of a liquid and is applied in the chemical disinfection of reusable medical and dental equipment to help protect patients from healthcare-associated infections. Endoscope reprocessing is categorized into two types, flexible and rigid, and is utilized by various end users such as hospitals, ambulatory surgical centers and clinics, and other healthcare facilities.

The endoscope reprocessing market consists of sales of ultrasonic washer, sterilizer, washer disinfector, drying and storage cabinet. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The coffee market is segmented into roasted coffee; coffee concentrates, essences and extracts and other coffee.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.